Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Esophageal Neoplasms × Tiragolumab × Clear all

Phase

Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Small Cell Lung Carcinoma 2 Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Cisplatin 28 Fluorouracil 21 Paclitaxel 19 Radiotherapy 16 Docetaxel 10 Radiation 7 Esophagectomy 7 Neoadjuvant Therapy 6 Irinotecan 6 Carboplatin 6 Oxaliplatin 5 Leucovorin 5 Capecitabine 5 sintilimab 4 pembrolizumab 4 camrelizumab 4 TP protocol 4 Surgical Procedures, Operative 4 Drug Therapy 4 Chemotherapy, Adjuvant 4 Trastuzumab 3 Immunotherapy 3 Chemoradiotherapy 3 tislelizumab 2 nimotuzumab 2 S 1 (combination) 2 Radiotherapy, Adjuvant 2 Platinum Compounds 2 Nivolumab 2 Immune Checkpoint Inhibitors 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04540211 2025-10-28

SKYSCRAPER-08

Hoffmann-La Roche

Phase 3 Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡